N
Niki Karavitaki
Researcher at University of Birmingham
Publications - 175
Citations - 7702
Niki Karavitaki is an academic researcher from University of Birmingham. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 40, co-authored 147 publications receiving 6071 citations. Previous affiliations of Niki Karavitaki include University Hospitals Birmingham NHS Foundation Trust & Queen Mary University of London.
Papers
More filters
Journal ArticleDOI
Epidemiology and mortality of Cushing’s syndrome
Osamah Hakami,Osamah Hakami,Osamah Hakami,Shahzada Ahmed,Niki Karavitaki,Niki Karavitaki,Niki Karavitaki +6 more
TL;DR: The annual incidence of Cushing's syndrome ranges between 1.8 and 3.2 cases per million population as mentioned in this paper, and the main cause of death is cardiovascular disease highlighting the negative impact of cortisol excess on cardiovascular risk factors.
Journal ArticleDOI
Non-adenomatous pituitary tumours
Niki Karavitaki,John A.H. Wass +1 more
TL;DR: The most commonly diagnosed non-adenomatous pituitary tumours (craniopharyngiomas, Rathke's cleft cysts and meningiomas) are focused on and data on their pathogenesis, diagnosis and treatment is provided.
Journal ArticleDOI
Pituitary disorders in pregnancy
TL;DR: This review will focus on pituitary adenomas (prolactinomas, GH-secreting and ACTH-Secreting), their diagnostic handicaps and the recommendations for treatment, and the two pituitaries encountered in pregnancy, Sheehan’s syndrome and lymphocytic hypophysitis.
Journal ArticleDOI
Confusing genes: a patient with MEN2A and Cushing's disease
Auditi Naziat,Niki Karavitaki,Rajesh V. Thakker,Olaf Ansorge,Greg Sadler,Fergus Gleeson,Treena Cranston,Ann McCormack,Ashley B. Grossman,Brian Shine +9 more
TL;DR: This case suggests that in patients with Cushing’s disease who have other evidence of endocrine neoplasia, if MEN1 is excluded then MEN2 should be considered, and a diagnosis of mutation-negative MEN1, which was reviewed at regular intervals.
Journal ArticleDOI
Outcomes of Patients with Nelson's Syndrome after Primary Treatment: A Multicenter Study from 13 UK Pituitary Centers.
Athanasios Fountas,Athanasios Fountas,Athanasios Fountas,Eugenie S Lim,William Drake,Andrew S Powlson,Mark Gurnell,Niamh M. Martin,Khyatisha Seejore,Robert D Murray,James Macfarlane,Rupa Ahluwalia,Francesca Swords,Muhammad Ashraf,Aparna Pal,Zhuomin Chong,Marie Freel,Tala Balafshan,Tejpal S Purewal,Rowena Speak,Rowena Speak,John Newell-Price,John Newell-Price,Claire E Higham,Ziad Hussein,Stephanie E Baldeweg,Jolyon Dales,Narendra Reddy,Miles J Levy,Niki Karavitaki,Niki Karavitaki,Niki Karavitaki +31 more
TL;DR: Complexity of treatments for the CD prior to NS diagnosis, possibly reflecting corticotroph adenoma aggressiveness, predicts long-term tumor prognosis.